347 studies found for:    dialysis [CONDITION] OR dialysis [TREATMENT] | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
dialysis [CONDITION] OR dialysis [TREATMENT] | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis
Conditions: Functionally Anuric;   Hemodialysis/Peritoneal Dialysis
Intervention: Other: Adjuvant Peritoneal Dialysis in the context of ongoing Hemodialysis
2 Recruiting The Effect of Intra-abdominal t-PA and and DNase on Peritonitis in Peritoneal Dialysis Patients
Conditions: Peritoneal Dialysis;   Peritoneal Dialysis, Continuous Ambulatory
Interventions: Drug: Tissue Plasminogen Activator (tPA);   Drug: recombinant deoxyribonuclease (DNase)
3 Recruiting Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis
Conditions: End Stage Renal Disease;   Peritoneal Dialysis
Intervention:
4 Not yet recruiting Virtual Ward for Home Dialysis
Conditions: End Stage Renal Disease;   Kidney Failure;   Home Dialysis
Interventions: Other: Telephone follow-up;   Other: Sympton Assessment
5 Recruiting Prevention of Peritonitis in Peritoneal Dialysis
Conditions: Kidney Failure, Chronic;   Peritoneal Dialysis-associated Peritonitis;   Dialysis Capd Infection
Intervention: Behavioral: Follow-up of PD patients´ theoretical and practical skills
6 Recruiting An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Conditions: Healthy Subjects;   Cytomegalovirus Infection;   Dialysis
Interventions: Drug: ASP0113;   Drug: Placebo
7 Unknown  Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments
Condition: Cardiovascular Disease
Intervention: Procedure: dialysis
8 Unknown  Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Conditions: End-Stage Kidney Disease;   Peritoneal Dialysis
Intervention: Drug: N-acetylcysteine
9 Unknown  The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
Conditions: Peritoneal Dialysis;   Hemodialysis
Intervention:
10 Recruiting A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
Conditions: End Stage Renal Failure on Dialysis;   Complication of Dialysis;   Blood Coagulation Disorders
Intervention:
11 Recruiting Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis
Condition: Peritoneal Dialysis Associated Peritonitis
Intervention: Other: endotoxin assay in peritoneal dialysis effluent
12 Unknown  Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
Conditions: Renal Failure, End Stage;   Peritoneal Dialysis
Intervention: Drug: Simvastatin
13 Recruiting Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD
Condition: Chronic Kidney Failure
Intervention: Drug: Solution for Peritoneal Dialysis
14 Recruiting Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis
Conditions: End-stage Renal Disease (ESRD);   Kidney Disease
Interventions: Other: DIANEAL;   Other: EXTRANEAL
15 Recruiting The Effects Nutrition Status and Body Composition On Peritoneal Dialysis Outcome
Conditions: Peritoneal Dialysis;   Wasting and Malnutrition
Intervention:
16 Unknown  Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
Condition: Peritoneal Dialysis
Intervention: Drug: alendronate (Fosamax)
17 Unknown  Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients
Conditions: ESRD;   Peritoneal Dialysis
Intervention: Drug: Oral N-Acetylcysteine 1200 mg x 2/day for 4 weeks.
18 Unknown  Bioimpedance as a Tool for Fluid Management in Peritoneal Dialysis (PD) Patients
Conditions: Fluid Status;   Peritoneal Dialysis
Intervention:
19 Recruiting Effect of Bio-impedance Analysis and Vitamin D vs Usual Care on Left Ventricular Mass in Peritoneal Dialysis Patients: A Randomized Controlled Trial (FLUID Study)
Condition: Peritoneal Dialysis
Interventions: Drug: Bioimpedance and Vitamin D;   Drug: Usual care and placebo;   Drug: Usual care and Vitamin D;   Device: Bioimpedance and Placebo
20 Unknown  Study to Evaluate the Protective Effect of α-Keto Acid With Low-Protein Diet (LPD) on Renal Function (RRF) in Peritoneal Dialysis (PD) Patients
Condition: Continuous Ambulatory Peritoneal Dialysis
Interventions: Dietary Supplement: α-Keto Acid with low protein diet;   Dietary Supplement: Normal protein diet

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years